Veranova

Activities: Manufacturing Ingredients

Trending Articles

  1. CARBOGEN AMCIS introduces SPRINT for early-phase development A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
  2. Free workshop – Measuring and characterising polymers workshop Anton Paar UK announces 2026 Polymer Processing and Characterisation Workshop in Luton
  3. FDA inspections and Form 483 responses: What companies need to know NSF experts explain how companies can strengthen Form 483 responses, improve CAPA planning and reduce regulatory risk following FDA inspections
  4. CSL's Seqirus discontinues production of Benpen amid generic competition The company cited competition from generics as its reason behind the discontinuation, with the TGA saying that supply of the injection will continue until existing stock is gone
  5. Shimadzu launches integrated HPLC/UHPLC systems These compact, robust instruments feature Analytical Intelligence with auto-diagnostics and auto-recovery, reducing downtime and operator workload

Upcoming event

CPhI North America

2–4 June 2026 | Exhibition | Pennsylvania, US See all

Related Content

Manufacturing

Veranova appoints Chief Quality Officer

Jacquelyn Martin will assume global leadership of Veranova’s Quality and Regulatory functions, supporting the company’s continued drive for excellence in quality and compliance and growth in advanced pharmaceutical modalities
Regulatory

Veranova’s Devens site passes FDA inspection with zero observations

This result demonstrates Veranova’s commitment to driving the highest standards of quality and compliance, and delivering consistent and reliable product supply for customers and patients

Veranova appoints Thomas Rohrer as vice president of bioconjugation

Industry veteran to lead expanding cGMP capabilities for ADC and bioconjugate development
Manufacturing

Veranova appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Dr. Villain will bring extensive expertise in peptide and oligonucleotide development and manufacturing to Veranova as the company continues to strengthen its position as a key player in the Peptide and Oligonucleotide (TIDES) space
Manufacturing

Veranova announces cGMP bioconjugation expansion in Devens

$50 million investment to support ADC manufacturing and create 70 new jobs
Manufacturing

Veranova appoints Elizabeth Rebeil as Global Vice President

Veranova appoints Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence
Manufacturing

Veranova to expand US ADC and API capabilities with $30m investment

The extension of the Devens, Massachusetts site will allow Veranova to serve the growing demand of ADC manufacturing in the US
Subscribe now